As the year starts, take a look at some of the fastest growing stocks in the market today for a possible life-changing investment.
9 Fastest Growing Stocks for Portfolio Expansion
1. CBS Corp.
Investors who regularly watch CBS know how well the multimillion-dollar network is currently performing.
Top Barrington stocks analyst, James Goss, has predicted a 44% bullish upside for the American mass media powerhouse. He states that it’s not impossible for CBS Corp. to hit more than eight million subscribers to CBS All Access and SHOWTIME’s direct-to-consumer products before 2020.
If that happens, those properties alone could generate roughly more than a $1-billion for CBS Corp.
Meanwhile, topnotch Benchmark stocks analyst, Daniel Kernos, predicted the highest price target of $81. Investors who feel that CBS Corp. may become the next Netflix, Inc. might want to consider including this stock in their IRA.
Bullish Definition: A stock market term that means the market will go up in a profitable direction.
2. Heron Therapeutics Inc.
What sets Heron Therapeutics Inc. a notch above the other fastest growing stocks is its focus on developing new pain and cancer treatments. Its performance in the past months has convinced analysts that Heron Therapeutics Inc. might experience 100% growth from 2018 to 2019.
In fact, top Needham stocks analyst, Serge Belanger, predicts a $66 price target in the next twelve months. If this does happen, investors can possibly enjoy a profit that exceeds well over 100%.
Similarly, Carl Byrnes, a four-star Northland Securities analyst, assumes a bullish price target of $55. This equates to around a 95% growth for the shareholders.
Apart from its potential growth, investors will be happy to know that their investment in Heron Therapeutics Inc. will help advance today’s medical technology.
Of course, if the company were to acquire sufficient funds in 2019, investors might potentially enjoy a profitable increase. But what really matters is the fact that investors of Heron Therapeutics Inc. might be funding the next medical breakthrough of the century.
3. Expedia Inc.
Investors may not know what Expedia Inc. is, but they’re bound to know its websites such as Trivago and HomeAway. Analysts are hopeful that new CFO Mark Okerstorm will steer the company to acquire better, more profitable assets making it among the fastest growing stocks of the year.
RBC Capital stocks analyst, Mark Mahaney, is especially hopeful about the growth of HomeAway. Mahaney says since they’ve secured a spot second to Airbnb, there is plenty of room for them to grow.
Trivago is already in a league of its own by dominating the international hotel-booking industry. Of course, that doesn’t mean Expedia Inc. might not expand Trivago even further.
Mahaney posted a buy rating and a price target of $175 on Expedia Inc. This equates to a bullish upside of more than 20% for company shareholders.
Investors who want Expedia Inc. to expand and improve its sites often become a shareholder. This might be what the company needs to acquire revenue-increasing assets for the company and its investors.
Buy Rating Definition: A professional analyst rating advising investors that the asset is currently undervalued so it may be a good time to buy it.
4. Adobe Inc.
Digital art buffs should know Adobe Inc. all too well. They’re a leading software developer that created the world-renowned Acrobat Reader and Adobe Photoshop.
With its recent development, despite the price volatility, the company received multiple buy ratings over the last months of 2018.
Pipe Jaffray stocks analyst, Alex Zukin, predicts a $180 price target for the company in 2019. This kind of growth equates to a 22% bullish market upside for company shareholders.
To entice investors, Adobe CFO Mark Garrett claims that more and more customers are becoming dependent on their products. Garrett states that this may be something shareholders can look forward to.
Investors are often confident in Adobe Inc.’s programs and are familiar with their history. After all, no investor would buy shares from a company they don’t believe in.
5. Neurocrine Biosciences Inc.
One of the fastest growing stocks in the biopharmaceutical industry is the Neurocrine Biosciences Inc., a California-based biopharmaceutical company that works to develop and discover treatments and advancements for neurological and endocrine-related disorders and diseases.
In the last quarter of 2018, Neurocrine Biosciences Inc. received more than seven buy ratings in just three months. Overall, top analysts still predict a bullish potential of almost 30%.
What allowed Neurocrine Biosciences Inc. to secure a spot among the fastest growing stocks is Ingrezza, which is their top-tier drug for the treatment of tardive dyskinesia, a movement disorder.
In fact, stock prices soared by more than 20% in April 2018 when the FDA granted approval on Ingrezza. Apart from its proven effectiveness in treating movement disorders, Ingrezza is competitively priced.
In fact, Jay Olson from Oppenheimer is confident in their buy rating since they don’t feel the threat of a rival treatment heading to the market any time soon. They state that it’s effective, safe, easy-to-use, and cost-efficient.
6. Alexion Pharmaceuticals
Another promising company in the medical industry’s fastest growing stocks is Alexion Pharmaceuticals. Patients and specialists across the globe may know this company as the genius behind Soliris.
Today, the company continues to further its immune system research to solve problems involving autoimmune diseases. A lot of investors choose to become a company shareholder since they believe Alexion Pharmaceuticals might hold the key to curing different autoimmune diseases.
Top analysts, including Leerink Swann analyst, Geoff Porges, believes that Alexion Pharmaceuticals will reach a $182 price target before the year comes to a close. This translates to roughly around 30% of upside growth for shareholders.
Alexion Pharmaceutical’s Soliris is currently unrivaled in immune system research and development. No other drug can work for a typical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria like Soliris.
Investors who want to be involved in the immune system research of Alexion Pharmaceuticals often buy company shares. Who knows, autoimmune diseases may soon be a thing of the past, right?
7. Netflix, Inc.
Investors all across the globe may be familiar with American media-service provider Netflix, Inc. In fact, a large percentage of them may already have an account.
What truly makes Netflix, Inc. among the fastest growing stocks for 2019 is its subscription-based business model, which costs only about $10 each month. This amount is too small for many to even notice in a credit card statement. An American earning minimum wage can already earn this in less than two hours of work.
While it may be a meager amount for the users, this monthly fee is what has allowed Netflix, Inc. to enjoy a 2,600% growth from 2013. On top of that, it doesn’t seem like Netflix, Inc. is losing its spot any time soon.
Out of 32 topnotch analysts, 25 gave a buy rating on Netflix, Inc., while five advise to hold on to it, and only two want investors to sell their shares.
Meanwhile, the average 12-month price target is $393.13. Keep in mind that the highest estimate is at a whopping $500.
8. Intuit Inc.
Taxpayers may be familiar with TurboTax and QuickBooks. These are programs that help people file taxes and manage finances efficiently.
As most people know, tax rules change almost on a yearly basis. Up until only a decade ago, this inconsistency forced accountants and taxpayers to purchase new the new rules on CD each year.
Similarly, Intuit Inc. used to spend millions costs every year for shelf space and CD manufacturing. In fact, from 2006 to 2009, revenue increased by 35% but their net profit increase was only at 14%.
However, in 2014, Intuit Inc. launched a cloud-based system of QuickBooks that offered premium subscription accounts. The company and its shareholders have then enjoyed a whopping 190% gain because of their innovation.
Intuit received seven buy ratings in the last three months with an average price target of $234.88. That equates to 10.85% upside for the company and its shareholders.
Intuit Inc. investors generally believe the company can continue expanding and improving its products such as QuickBooks and TurboTax.
9. Alphabet Inc. Class A
No list of fastest growing stocks would be complete without Alphabet Inc. Class A, a California-based multinational conglomerate that owns Google and plenty of its subsidiaries.
A lot of the things available on the internet are under this multibillion-dollar parent company. In fact, Alphabet Inc. Class A holds some of the fastest growing stocks such as Google, Verily, YouTube, Capital G, and DeepMind Technologies, among others.
In the last three months, Alphabet Inc. Class A has received 33 buy ratings out of 34 analysts. It has an average 12-month price target of $1,353.28 that translates to a 25.40% upside for shareholders.
These are just some of the fastest growing stocks to look into this year. Investors might benefit even more if they did their own research on what assets to include inside their IRA.
Perhaps the best course of action is to take professionals’ advice and combine it with one’s own personal decision. At the end of the day, whether one buys, sells, or holds an asset is completely up to them.
What are some of the fastest growing stocks you’d like to see on this list? Share them with us in the comments section down below!